SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-021169
Filing Date
2024-02-27
Accepted
2024-02-27 16:16:24
Documents
13
Period of Report
2024-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acad-20240227.htm   iXBRL 8-K 40113
2 EX-99.1 acad-ex99_1.htm EX-99.1 223738
  Complete submission text file 0000950170-24-021169.txt   390760

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20240227.xsd EX-101.SCH 25052
14 EXTRACTED XBRL INSTANCE DOCUMENT acad-20240227_htm.xml XML 4760
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 24686964
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)